By health Cash Flow Conversion Efficiency
By health cash flow conversion efficiency. Based on the latest financial reports, By health (300146) has a cash flow conversion efficiency ratio of 0.025x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥288.55 Million ≈ $42.22 Million USD) by net assets (CN¥11.40 Billion ≈ $1.67 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of By health (2007–2024)
Cash flow conversion efficiency of By health from 2007 to 2024. This chart illustrates how By health's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 300146 share price today for real-time trading data and today's change.
By health Cash Flow Conversion Ratio Explained
By health cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
By health Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of By health ranked by their cash flow conversion efficiency. Also see By health (300146) market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Quaker Chemical Corporation
NYSE:KWR
|
0.021x |
|
Sunway Construction Group Bhd
KLSE:5263
|
0.402x |
|
NCsoft Corp
KO:036570
|
0.010x |
|
Weihai Guangwei Composites Co Ltd
SHE:300699
|
-0.003x |
|
DB HiTek Co Ltd
KO:000990
|
0.037x |
|
Dream Industrial Real Estate Investment Trust
TO:DIR-UN
|
0.009x |
|
Shenzhen Chengxin Lithium Group Co Ltd
SHE:002240
|
0.069x |
|
Hang Zhou Iron & Steel Co Ltd
SHG:600126
|
0.124x |
Annual Cash Flow Conversion Efficiency for By health (2007–2024)
The table below shows the annual cash flow conversion efficiency of By health from 2007 to 2024. Review By health free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥11.10 Billion ≈ $1.62 Billion |
CN¥685.94 Million ≈ $100.37 Million |
0.062x | -63.11% |
| 2023-12-31 | CN¥12.24 Billion ≈ $1.79 Billion |
CN¥2.05 Billion ≈ $300.19 Million |
0.168x | +30.71% |
| 2022-12-31 | CN¥10.76 Billion ≈ $1.57 Billion |
CN¥1.38 Billion ≈ $201.78 Million |
0.128x | -25.74% |
| 2021-12-31 | CN¥10.54 Billion ≈ $1.54 Billion |
CN¥1.82 Billion ≈ $266.17 Million |
0.173x | -23.49% |
| 2020-12-31 | CN¥6.94 Billion ≈ $1.02 Billion |
CN¥1.57 Billion ≈ $229.21 Million |
0.226x | -12.90% |
| 2019-12-31 | CN¥5.93 Billion ≈ $867.95 Million |
CN¥1.54 Billion ≈ $224.84 Million |
0.259x | +32.26% |
| 2018-12-31 | CN¥6.89 Billion ≈ $1.01 Billion |
CN¥1.35 Billion ≈ $197.41 Million |
0.196x | +5.33% |
| 2017-12-31 | CN¥5.13 Billion ≈ $750.97 Million |
CN¥954.31 Million ≈ $139.65 Million |
0.186x | +27.75% |
| 2016-12-31 | CN¥4.70 Billion ≈ $688.30 Million |
CN¥684.65 Million ≈ $100.19 Million |
0.146x | +4.40% |
| 2015-12-31 | CN¥4.55 Billion ≈ $666.37 Million |
CN¥634.89 Million ≈ $92.90 Million |
0.139x | -39.13% |
| 2014-12-31 | CN¥2.45 Billion ≈ $358.17 Million |
CN¥560.64 Million ≈ $82.04 Million |
0.229x | -18.37% |
| 2013-12-31 | CN¥2.23 Billion ≈ $326.73 Million |
CN¥626.51 Million ≈ $91.68 Million |
0.281x | +386.18% |
| 2012-12-31 | CN¥1.93 Billion ≈ $282.00 Million |
CN¥111.22 Million ≈ $16.28 Million |
0.058x | -41.75% |
| 2011-12-31 | CN¥1.76 Billion ≈ $256.98 Million |
CN¥173.99 Million ≈ $25.46 Million |
0.099x | +194.73% |
| 2010-12-31 | CN¥1.62 Billion ≈ $237.70 Million |
CN¥54.61 Million ≈ $7.99 Million |
0.034x | -91.41% |
| 2009-12-31 | CN¥107.00 Million ≈ $15.66 Million |
CN¥41.88 Million ≈ $6.13 Million |
0.391x | -34.77% |
| 2008-12-31 | CN¥42.27 Million ≈ $6.19 Million |
CN¥25.36 Million ≈ $3.71 Million |
0.600x | +4.07% |
| 2007-12-31 | CN¥22.21 Million ≈ $3.25 Million |
CN¥12.80 Million ≈ $1.87 Million |
0.577x | -- |
About By health
Byhealth Co., Ltd, together with its subsidiaries, provides dietary supplements in Mainland China, Hong Kong, Australia, and internationally. The company offers protein powder; collagen; bone health products, such as glucosamine, chondroitin, and calcium tablets; probiotics; capsules; and multivitamins. It sells its products under the By-Health, Jianli, LifeSpace and other brands through retail t… Read more